Company
Innovation1 Biotech Inc. (0001629205)
Standardized SEC financial data for Innovation1 Biotech Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001629205 · Pharmaceutical Preparations.
Return on equity
410.5%
Free cash flow
-$620K
Current ratio
0.02×
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Revenue | $17K | $79K | $1K | $3K | $0 | $0 |
| Cost of revenue | $81K |
Standardized from Innovation1 Biotech Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2022 | FY2022 | FY2022 | FY2023 | FY2023 | FY2023 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $156K | — | — | — | $50K |
| Inventory |
Cash flow
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$443K | -$776K | -$410K | -$30K | -$3.1M | -$620K |
| Capital expenditures |
Get 0001629205 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001629205/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001629205/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"